Aurora Cannabis Inc. (ACB) vs Tilray Brands, Inc. (TLRY)

Aurora Cannabis Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Tilray Brands, Inc. is the larger, with a market value of $415.3M against $341.2M — 1.2× the size. Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against −18.2%. Tilray Brands, Inc. has the higher net margin (−17.1% vs −38.1%) and the higher return on invested capital (−3.21% vs −5.58%). Across the 18 metrics below, Tilray Brands, Inc. leads on 11 and Aurora Cannabis Inc. on 7.

Valuation

Metric ACB TLRY Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.53 0.39 2.08
P/B 0.84 0.23 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.28 0.52 2.87
Earnings yield (27.12%) (49.82%) (15.94%)
Free cash flow yield (11.26%) (49.10%) 0.00%

Profitability

Metric ACB TLRY Drug Manufacturers Specialty & Generic median
Gross margin 49.74% 29.12% 53.51%
Operating margin (12.13%) (9.26%) 0.00%
Net margin (38.12%) (17.05%) (2.45%)
Free cash flow margin (17.19%) (19.10%) 0.00%
Return on equity (19.85%) (10.50%) (0.80%)
Return on assets (15.19%) (7.45%) (1.67%)
Return on invested capital (5.58%) (3.21%) 0.00%

Growth

Metric ACB TLRY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (18.18%) 15.93% 5.22%
EPS growth (last fiscal year) (5,266.67%) 95.57% 42.91%
Revenue growth, 5-year CAGR 3.92% 7.82% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACB TLRY Drug Manufacturers Specialty & Generic median
Debt to equity 0.03 0.22 0.04
Current ratio 5.36 1.88 2.41
Net debt to EBITDA 5.11 11.34 1.01

Dividend

Metric ACB TLRY Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ACB TLRY Drug Manufacturers Specialty & Generic median
Market cap 341.19m 415.28m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack